Abstract
250P - Relationship between progression-free survival and overall survival in advanced breast cancer: a novel approach using first-line treatment data for fulvestrant 500 mg and anastrozole
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have